[Photodynamic therapy for non-melanocytic skin cancer treatment]

Pichon Riviere A, Augustovski F, Garcia Marti S, Glujovsky D, Alcaraz A, Lopez A, Bardach A, Ciapponi A, Gonzalez L
Record ID 32014000275
Authors' objectives: To assess the available evidence on the efficacy, safety and coverage policy related aspects on the use of photodynamic therapy in patients with melanocytic skin cancer.
Authors' recommendations: The evidence found is of moderate methodological quality. Although PDT had certain advantages from an esthetic point of view, the rates of recurrence at one and five years were worse when using PDT. These results may be even more relevant due to the short follow up period of the studies identified and the screening bias favoring lesions with low recurrence risk. Regarding SCC, evidence is scarce and of poor methodological quality, therefore the use of PDT is not recommended. PDT might be useful for those patients who may not undergo surgery or if SSR is debilitating and when it is important to get good esthetic results. Low risk BCC would be its main indication.
Project Status: Completed
Year Published: 2012
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Humans
  • Photochemotherapy
  • Photosensitizing Agents
  • Skin Neoplasms
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.